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Eﬀects of GSE and vitamins C and E on aspirin- and ethanol-induced gastric ulcer and associated increases of lipid peroxidation
in rats were compared. Two experiments were conducted. Rats were randomized into eight groups: a negative control and seven
groups that received aspirin or ethanol for ulcer induction: one positive control (vehicle) and six with VC, VE, or GSE (25 and
250mg/kg). Ulcer indexes and gastric levels of malondialdehyde (MDA) were quantiﬁed. VC, VE, and GSE (25 and 250mg/kg)
decreased aspirin, and ethanol-induced ulcers and MDA values compared with positive control group. The magnitude of aspirin
ulcer reduction was comparable for all treatments, and MDA decrease with GSE was higher than with VC and tended to be greater,
albeit none signiﬁcantly, than with VE. GSE was more eﬀective than VC and VE for lowering the ethanol ulcers, while the decrease
of MDA levels with GSE was greater than with VC, but comparable to that achieved with VE. GSE protected against ethanol-
induced gastric ulcers more eﬀectively than VC or VE, while its protection against aspirin ulcers was comparable for all treatments.
GSE produced the greatest reductions of gastric MDA in both models.
1.Introduction
Peptic ulcer, a common gastrointestinal pathological condi-
tion, is due to the loss of the balance between aggressive
and defensive factors of the gastric and duodenal mucosa.
Aggressive factors against gastric mucosa include acid,
pepsin, Helicobacter pylori, nonsteroidal anti-inﬂammatory
drugs (NSAIDs), and ethanol, while local mucosal defensive
factors include bicarbonate, mucus secretion, blood ﬂow,
cellular regeneration, and endogenous protective agents like
prostaglandins (PG) and epidermal growth factors [1–3].
Also, increased oxidative stress is believed to be linked to the
aggressive factors-induced gastric mucosal damage [4, 5].
The pathogenesis of NSAIDs-induced gastric ulceration
includes the block of cyclooxygenase (COX) activity that
leads to lower mucus and bicarbonate secretion, decreased
mucosal blood ﬂow, neutrophil inﬁltration, alteration of
microvascular structures, and increase of acid and pepsino-
gen secretion. In addition, increased production of reactive
oxygen species (ROS), increased lipid peroxidation, and
neutrophil inﬁltration have demonstrated to play a role in
the pathogenesis of NSAIDs-induced ulcers, including the
aspirin-induced ulcer [6–11].
On the other hand, increased oxidative stress plays a key
role in the pathogenesis of ethanol-induced gastric damage,
so that as oral ethanol produces gastric mucosal lesions
and erosions, it increases lipid peroxidation, raises hydroxyl
radicals generation, and causes DNA damage, while it lowers
the gastric content of reduced glutathione. Also, ethanol-
induced ulceration is linked to reduced mucosa microcircu-
lation and to increased apoptosis [12–16].
Vitamin C (VC) (ascorbic acid) is a water-soluble antiox-
idant that directly scavenges ROS, like superoxide and hy-
droxyl radicals, hydrogen peroxide, singlet oxygen, and hy-
pochlorous acid, and also guarantees the chain-breaking
antioxidant action of vitamin E (VE) by reducing the VE
radical to VE [17, 18]. In addition, VC has been shown
to attenuate aspirin-induced gastric damage and to oﬀer
eﬀective gastroprotection [19, 20].2 Advances in Pharmacological Sciences
In turn, VE (alpha-tocopherol), a lipid-soluble antioxi-
dant that scavenges ROS and functions as a chain-breaking
antioxidant for peroxidation of membrane lipids, has been
shown to inhibit neutrophils adhesion to endothelial cells
and the oxygen production in activated neutrophils [21–
23]. Antiulcer eﬀects of VE on aspirin- and ethanol-induced
ulcers have been reported [24–26].
Grape seed extracts (GSEs), rich in ﬂavonoids, mainly
proanthocyanidin, have been shown to produce eﬀec-
tive antioxidant eﬀects [22–30]. Experimental studies have
shown that oral administration of GSE lowers ROS genera-
tion and plasma protein carbonyl groups, while it enhanced
the activity of the endogenous antioxidant system [27–30].
Clinical trials have conﬁrmed the antioxidant eﬀects of GSE
[31–33]. The antiulcer activity of GSE has been also referred
[33].
In light of these issues and to our knowledge (Entrez
PubMed review up to July 2011), no previous study com-
pared the preventive eﬀects of GSE, VC, and VE against
aspirin- and ethanol-induced gastric ulceration and associ-
ated increases of lipid peroxidation; this study was aimed to
do such comparison.
2.MaterialsandMethods
2.1. Animals. Male Sprague Dawley rats (200–250g) from
the National Center for Laboratory Animal Production
(CENPALAB,HavanaCity,Cuba)wereadaptedtolaboratory
conditions (25 ± 2◦Co ft e m p e r a t u r e ,6 0± 5% of relative
humidity, and 12-hour light/dark cycles) for 7 days. Food
(rodent pellets from CENPALAB) and tap water were
provided ad libitum.
Experiments were conducted in accordance to the Cuban
guidelines of Animal Handling and the Cuban Code of Good
Laboratory Practices (GLP), which follow international
guidelines for the use and care of laboratory animals. Study
protocol and animal use were approved, prior to study
beginning, by an independent Animal Ethics Committee.
2.2. Administration and Dosage. GSE (85% in proantho-
cyanidine) came from Blackmores (Sydney, Australia), and
VC (Cuban Pharmaceutical Industry) was prepared as a
suspension in acacia gum/water vehicle (1%), while VE
(Carlson health, VIC, Australia), was suspended in a Tween
65/water suspension (2%). All suspensions were prepared
daily, 1 hour before use and administered by oral gastric
gavage (5mL/kg of body weight) for 10 days.
Two independent experiments were conducted, in which
rats were randomized into eight groups: a negative control
and seven groups that received aspirin or ethanol for ulcer
induction: one orally treated with the vehicle (positive
control) and the other six with 25 and 250mg/kg of VC, VE,
or GSE, respectively.
2.3. Experimental Induction of Gastric Ulcers. The animals
were fasted for 24 hours before the experiments with free
access to water.
In both experiments, rats were sacriﬁced in ether atmo-
sphere and their stomachs were immediately removed for
quantifying the lesions.
2.3.1. Aspirin-Induced Gastric Ulcers. Following one hour of
administering the last doses of vehicle, GSE, VC, or VE, a
single oral dose of aspirin (300mg/kg) was given by gastric
gavage. Five hours later, rats were sacriﬁced.
2.3.2. Ethanol-Induced Gastric Ulcers. We followed the pro-
cedure in accordance to Zengil et al. (1987) [34]. In brief,
one hour after the last administering of the vehicle, GSE,
VC, or VE, ethanol (60%) (1mL/200g body weight) was
intragastrically administered to each rat. One hour later, rats
were sacriﬁced.
2.4. Evaluation of Gastric Mucosal Damage. The stomachs
were opened along the greater curvature and washed with
saline solution. The lesions in the gastric mucosa were
examined macroscopically using magniﬁcation 3x. Ulcer
indexes were determined as the sum of the lengths of the
whole gastric lesions (in mm). Two independent, blinded
observers performed the observations and measurements of
lesion lengths [35].
2.5. Determination of Lipid Peroxidation (LP) in Gastric
Mucosa. Aliquots of gastric mucosa were obtained by gentle
scraped with a scalp. Lipid peroxidation was assessed as per
the content of thiobarbituric reactive substances (TBARS)
in the gastric mucosa and quantiﬁed in accordance to
Ohkawa et al. 1979 method [36], which has been widely
used for this propose [37–40]. Results were expressed as
nmolofmalondialdehyde(MDA)/mgofprotein.Theprotein
concentration was determined according to modiﬁed Lowry
method [41].
2.6. Statistical Analysis. Comparisons among groups were
performed with the Kruskal Wallis test, and paired compar-
isons with the Mann-Whitney U test. The level of statistical
signiﬁcance was set at α = 0.05. All analyses were performed
using Statistics software for Windows (Release 6.0, StatSoft;
Inc, USA).
3. Results and Discussion
Oral administration of GSE, VC, and VE, all at 25 and
250mg/kg, prevented aspirin- and ethanol-induced gastric
mucosal ulceration and reduced the increase of gastric MDA
elicited by these aggressive agents. To our knowledge (Entrez
PubMed review up to July 2011), this study is the ﬁrst
comparative study of the gastroprotective eﬀect of GSE with
those of VC and VE against aspirin- and ethanol-induced
ulceration and concomitant increase of lipid peroxidation on
the rat gastric mucosa.
No negative, but all positive controls exhibited typical
aspirin-inducedgastriculcers.Aspirinincreasedsigniﬁcantly
MDA gastric concentrations as compared to the negative
controls (Table 1). Both doses of each treatment reducedAdvances in Pharmacological Sciences 3
Table 1: Eﬀects of GSE, VC, and VE on ulcer indexes and MDA gastric concentrations in rats with aspirin-induced ulcer.
Treatment Doses (mg/kg) Ulcer index (mm) I (%) MDA (nmol/mg of pt) I (%)
Negative control (vehicle) 0 0 ± 0∗∗∗∗ —1 . 0 2 ± 0.21∗∗ —
Positive control (vehicle + aspirin) 0 27.06 ± 5.60 — 12.28 ± 0.81 —
VC + aspirin 25 10.91 ± 2.33∗∗ 59.7 8.7 ± 0.28∗∗∗ 31.8
VC + aspirin 250 8.36 ± 1.23∗∗∗ 69.1 4.69 ± 0.92∗∗ 67.4
VE + aspirin 25 13.72 ± 3.60∗ 49.3 6.33 ± 0.86∗∗∗ 52.8
VE + aspirin 250 10.31 ± 2.70∗ 61.9 3.11 ± 0.43∗∗∗ 81.4
GSE + aspirin 25 11.56 ± 3.50∗ 57.3 5.11 ± 0.79∗∗∗a 63.6
GSE + aspirin 250 11.81 ± 3.03∗ 56.3 1.95 ± 0.28∗∗∗at 91.7
GSE: grape seed extract, VC: vitamin C, VE: vitamin E, MDA: malondialdehyde.
Data as means ± MSE (mean standard error).
∗P<0.05, ∗∗P<0.01, ∗∗∗P<0.001; comparisons with positive controls, aP<0.01; comparisons with the same dose of VC; tP = 0.054; comparisons with
that of VE, (Mann-Whitney U test).
Table 2: Eﬀects of GSE, VC, and VE on ulcer indexes and MDA gastric concentrations in rats with ethanol-induced ulcer.
Treatment Doses (mg/kg) Ulcer index (mm) I (%) MDA (nmol/mg of pt) I (%)
Negative control (vehicle) 0 0 ± 0∗∗∗∗ —1 . 0 2 ± 0.21∗∗ —
Positive control (vehicle + ethanol) 0 72.27 ± 8.43 — 18.72 ± 0.76 —
Vit C + ethanol 25 32.32 ± 10.1∗ 55.2 10.71 ± 0.54∗∗∗ 45.2
Vit C + ethanol 250 32.67 ± 8.8∗∗ 54.8 7.93 ± 0.88∗∗∗ 61.0
Vit E + ethanol 25 40.94 ± 9.6∗ 43.3 11.03 ± 0.57∗∗∗ 43.4
Vit E + ethanol 250 29.21 ± 9.8∗∗ 59.6 5.02 ± 0.59∗∗∗ 77.4
GSE + ethanol 25 13.27 ± 4.8∗∗∗ab 81.6 7.84 ± 0.45∗∗∗aabb 61.4
GSE + ethanol 250 2.03 ± 0.69∗∗∗aab 97.2 4.00 ± 0.28∗∗∗aa 83.2
GSE: grape seed extract, VC: vitamin C, VE: vitamin E, MDA: malondialdehyde.
Data as means ± MSE (mean standard error).
∗P<0.05, ∗∗P<0.01, ∗∗∗P<0.001; comparisons with positive control, aP < 0.05, aaP < 0.01 comparisons with the same doses of VC, bP < 0.05, bbP <
0.01 comparisons with the same doses of VE, (Mann-Whitney U test).
the development of aspirin-induced gastric ulcers and atten-
uated the increase of gastric MDA.
Oral administration of VC, VE, and GSE 25mg/kg
decreased the ulcers (59.7%, 49.3%, and 57.3%, resp.) and
gastricMDA(31.8,52.8,and63.6%,resp.)versusthepositive
controls, while, at 250mg/kg, they produced ulcer reduc-
tions of 69.1%, 61.9%, and 56.3%, respectively, and MDA
decreasesof67.4,81.4,and91.7%,respectively(comparisons
versus positive control rats). The eﬀect of the highest doses
of each treatment revealed that the magnitude of ulcer
reduction was comparable for all treatments, while MDA
decrease with GSE was higher than with VC and tended to
be greater, albeit non signiﬁcantly (P = 0.058), than with
VE.
Oral administration of ethanol produced gastric ulcer-
ation and increased signiﬁcantly the MDA gastric content
(Table 2). All schemes protected against ethanol-induced
gastric damage and reduced MDA gastric levels. Treatment
with VC, VE, and GSE given at 25mg/kg reduced ethanol
ulcers (55.2%, 43.3%, and 81.6%, resp.) and attenuated
MDA increases (45.2%, 43.4%, and 61.4%, resp.), while
it at 250mg/kg, reduced the ulcers by 54.8%, 59.6%, and
97.2%, respectively, and decreased MDA by 61.0%, 77.4%,
and 83.2%, respectively, versus the positive controls.
OraltreatmentwithGSEreducedethanol-inducedulcers
more eﬀectively than VC and VE, while it produced reduc-
tions of MDA levels greater than VC, but similar to VE. The
lowest dose of GSE, however, lowered MDA concentrations
more than the same dose of VE.
Overall, GSE 25 and 250mg/kg produced greater percent
reductions of ethanol than aspirin-induced ulcers. The
reductions of gastric MDA levels with the lowest dose
(25mg/kg) of GSE were similar in both models, while the
MDA reduction with the highest dose (250mg/kg) seems to
be greater in rats with aspirin-induced ulceration.
The experimental models here used share similarities
and diﬀerences. Increased oxidative stress and ROS pro-
duction are pathogenic mechanisms of both models [4–
9, 12]. Nevertheless, the key mechanism of NSAID-induced
gastric ulceration results from the irreversible and nons-
elective inhibition of COX activity, which interferes with
the synthesis from PG, triggering the eﬀects derived of PG
depletion, and shuttles the arachidonic acid metabolism
towards the lipoxygenase pathway, increasing the formation
of vasoconstrictor leukotrienes (LTs) [6, 7, 10, 11].
The gastric ulceration induced by oral administration of
ethanol to rats involves other mechanisms in addition to the
increase of oxidative stress and ROS formation. So, ethanol4 Advances in Pharmacological Sciences
also depletes PG concentration due to its necrotizing action
on the gastric mucosa and, thus, shares the consequences
of PG as oral administration of aspirin does, as increased
vascular permeability and decreased gastric mucosa micro-
circulation. Also, the necrotizing action of ethanol decrease,
gastric mucus secretion and impairs the quality of mucus
composition [42].
T h ep r o t e c t i v ee ﬀect of VC involves the reduction of
lipid peroxidation in the gastric mucosa, which preserves the
gastric microcirculation. VC stimulates the expression of the
antioxidant and vasodilator heme oxygenase enzyme in the
gastric epithelium and inhibits the expression of inducible
nitric oxide synthase enzyme [9, 43, 44]. It makes sense,
therefore, that VC had been eﬀective to protecting against
both aspirin- and ethanol-induced ulcers. The highest dose
of VC reduced aspirin-induced ulcer more markedly (about
70%) than ethanol ulcers (about 55%), while the eﬀects on
gastric MDA (67% and 61%, resp.) were comparable. These
results suggest that although the eﬀects of VC against aspirin
and ethanol ulcers may be attributable to the reduction of
lipidperoxidation,thisisnottheonlymechanisminvolvedin
the gastroprotective eﬀect on aspirin-induced ulcers. Further
studies must dilucidate the direct or indirect mechanism
of action that supports the gastroprotective and antioxidant
eﬀects of Vitamin C.
Oral administered VE has been shown to be eﬀective
against ethanol and NSAIDs-induced ulcers, an action that
involves the reduction of lipid peroxidation and the increases
of the activity of endogenous antioxidant enzymes, like
superoxide dismutase, catalase, and glutathione peroxidise
[25–27]. Then, the fact that VE was eﬀective in the two mod-
els here used was expected. The highest dose of VE produced
similar reductions (about 60%) of aspirin- and ethanol-
induced ulcers and of MDA values (roughly about 80%).
Then, although these results suggest that the gastroprotective
eﬀects of VE may be related to its antioxidant eﬀects, these
last ones seem to be greater, a ﬁnding without conclusive
explanation.
The eﬀect of VC for protecting against aspirin-induced
ulcers(∼ =70%ofinhibition) wasapparently,notsigniﬁcantly,
greater than that of VE (∼ =62% of inhibition), while the
eﬀects of both treatments on ethanol ulcers were grossly
comparable. This result, however, is slightly diﬀerent from
that reported in the model of water-restrain-stress- (WRS-
) induced ulcers, in which VE was more eﬀective than VC,
despite the fact that both substances exerted their protective
actions through antioxidant and anti-inﬂammatory eﬀects
[45].
Oral administration of GSE protected against ethanol-
induced gastric ulcers in rats more eﬀectively than VE
and VC, wherein the lowest dose of GSE produced a
reduction of these ulcers (about 82%) and the highest dose
practically abolished (about 97% reduction) the ethanol-
induced ulcers. Although the decreases of MDA levels with
GSE (∼ =83%) were greater than with VC (∼ =61%) or VE
(∼ =77%), it should be noted that ethanol ulcer reduction
with GSE was greater than MDA decreases, consistent with
the fact that the protection of GSE against ethanol-induced
ulcers depends not only on its scavenging properties, but
on its ability for lowering increase MPO and consequent
neutrophil inﬁltration [25, 46]a sw e l l .
The magnitude of aspirin-induced ulcer reduction, com-
parable for all treatments, was apparently greater with VC
250mg/kg (about 70%) than with the same dose of GSE
(about 57%). By contrast, the same dose of GSE decreased
MDA (about 97%) more markedly than VC (about 83.2%).
These results suggest that although the eﬃcacy of GSE on
this model should be attributable to its ability to lower lipid
peroxidation, it did not reduce other mechanisms leading to
aspirin-induced ulcers.
4. Conclusions
GSE prevented ethanol-induced gastric ulcers more eﬀec-
tively than VC or VE, while its protection against aspirin
ulcers was comparable for all treatments. GSE produced
the greatest reductions of gastric MDA in both models.
Then, the gastroprotective eﬀects of GSE may be related, at
least partially, to its ability for reducing lipid peroxidation
in the gastric mucosa. Further studies must compare the
therapeutic eﬀects of GSE, VC, and VE on ethanol- and
aspirin-induced gastric ulcer in rats.
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